← Browse by Condition
Medical Condition
multiple myeloma in relapse
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, Phase 2
NCT04162353 Phase 1
Recruiting
BCMA-CD19 cCAR in Multiple Myeloma and Plasmacytoid Lymphoma
Enrollment
12 pts
Location
China
Sponsor
iCell Gene Therapeutics
NCT06827860 Phase 2
Recruiting
Subcutaneous Talquetamab in Elderly Patients With Multiple Myeloma in Early Relapse
Enrollment
23 pts
Location
United States
Sponsor
Larysa Sanchez
NCT07248176
Recruiting
Universal CAR-T Cell Therapy for MM
Enrollment
6 pts
Location
China
Sponsor
Bioray Laboratories